Global Innovative Platforms GIPL
OTC GIPL
$0.05 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Global Innovative Platforms (GIPL) Change in Receivables (2026)

Updated

Global Innovative Platforms' Change in Receivables came in at -$3,300 for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Global Innovative Platforms (GIPL) Change in Receivables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -188.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -312.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -52.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Global Innovative Platforms 2.49 Mn 1.88 Mn - -3,300.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,300.00
API Access

Global Innovative Platforms Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GIPL&period=max&api_key=YOUR_API_KEY